Letters to the editor
Vol. 1 No. 1 (2017)
https://doi.org/10.4081/tmr.6421

Functional drug response assay for cancer stem cells in the era of precision medicine

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 28 November 2016
Published: 16 January 2017
2097
Views
654
Downloads
1986
HTML
Precision medicine, Personalized medicine, Drug response assay, Chemo-sensitivity assay, Chemo-resistance assay

Authors

Candace M. Howard
Department of Radiology, University of Mississippi Medical Center, Jackson, MS, United States.
Jagan Valluri
Department of Biological Sciences, Marshall University, Huntington, WV, United States.
Pier Paolo Claudio
pclaudio@olemiss.edu
Department of BioMolecular Sciences, National Center for Natural Products Research, University of Mississippi, University, MS; Department of Radiation Oncology, University of Mississippi Medical Center Cancer Institute, Jackson, MS, United States.
Not available.

Downloads

Download data is not yet available.
Candace M. Howard, Department of Radiology, University of Mississippi Medical Center, Jackson, MS

Assistant Professor

Department of Radiology,

University of Mississippi Medical Center

Jackson, MS 39216.

Jagan Valluri, Department of Biological Sciences, Marshall University, Huntington, WV

Professor

Department of Biological Sciences,

Marshall University,

Huntington, WV 25755.

How to Cite



Functional drug response assay for cancer stem cells in the era of precision medicine. (2017). Translational Medicine Reports, 1(1). https://doi.org/10.4081/tmr.6421

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.